Cerner Corporation (CERN) Falls 2.73% for February 08

Equities Staff |

One of the S&P 500’s big losers for Monday February 08 was Cerner Corporation (CERN). The company’s stock fell 2.73% to $53.80 on volume of 1.67 million shares.

The stock opened the day at 54.89 and traded between a low of $52.91 and a high of $54.97. The stock finished the day down $1.51 per share. Cerner Corporation has an average daily volume of 2.3 million and a total float of 342.1 million shares. The 50-day SMA for Cerner Corporation is $58.75 and its 200-day SMA is $64.02. The high for the stock over the last 52 weeks is $75.72 and the low is $53.91.

Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Cerner Corporation is centered in North Kansas City, MO, and has 15,800 employees. Today’s trading day leaves the company with a market cap of $18.41 billion. The company has a P/S ratio of n/a, P/B ratio of 4.8, and a -19.7.

For a complete fundamental analysis analysis of Cerner Corporation, check out Equities.com’s Stock Valuation Analysis report for CERN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

THC Therapeutics Inc

THC Therapeutics Inc is a health and healing company in the cannabis industry. The Company is engaged in developing dHydronator which is used to reduce moisture and effectively dry out…

Private Markets

California Green Tree Development

California Green Tree Development LLC (CGTD) is a for-profit LLC that plans on using California’s booming market of legal cannabis products for medical purposes. As an unprecedented resource, Cannabis has…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…